Glivec (imatinib) CML and GIST Treatment Glivec, CML, and GIST Treatment Information for International Healthcare Professionals Glivec, CML  and GIST Treatment Information for US Residents International Glivec Information from Novartis Oncology Click here to go to Novartis.com Novartis Oncology International Site
International Glivec Information from Novartis Oncology
Ask a question
Haematology and Oncology News from Glivec.com

Our weekly newsletter keeps you informed of the latest haematology and oncology news.

Help us improve Glivec.com.
Please take our short survey.

 
Glivec Home
About Glivec For Your Patients
  Glivec Timeline   GIPAP
  Molecular Target   Common Patient Questions
  Human Impact  
  References News & Events
  Glivec virtual Booth
CML   Recent Publications
  About CML   Haematology News
  Symptoms   Oncology News
  Diagnosis   Events
  Treatment Options Resources
  Glivec & CML     CML Resources
  Prescribing Glivec   GIST Resources
  Ongoing Management   Related Links
  Frequently Asked Questions
  References European Summary of Product Characteristics
GIST
  About GIST
  Symptoms
  Diagnosis
  Treatment Options
  Glivec & GIST
  Prescribing Glivec
  Ongoing Management
  Frequently Asked Questions
  References


Disclaimer: This is an international website for Glivec (imatinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the For US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.



Use of this website is subject to our Terms of Use.
© 2008 Novartis Pharma AG